% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • fib1_1_2_3_5 fib1_1_2_3_5 Oct 17, 2012 7:57 AM Flag

    How does CLDX fit in the picture?

    That would be the first validation of SGEN's ADC technology for solid tumors. T-DM1 would be the first validation of any ADC in solids.

    I have not heard any financial terms. I suspect they are modest, but CDX-011 does have a large market potential so some "hard" value (in addition to validation as you mentioned).

33.10-1.89(-5.40%)May 4 4:00 PMEDT